Pelthos Therapeutics PTHS
NYSE PTHS
$21.50 +0.29 (+1.37%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Short term Debt (2024)

Updated

Pelthos Therapeutics (PTHS) recorded Short term Debt of $2.19 million in Q4 2024.

Analysis

Pelthos Therapeutics (PTHS) Short term Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pelthos Therapeutics 79.95 Mn -8.44 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2.19 Mn
API Access

Pelthos Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=PTHS&period=max&api_key=YOUR_API_KEY